Ultragenyx Pharmaceutical | RARE - Кредиторская задолженность

Биржевая цена
19.87
Изменение за день
-0.55 -2.69%
Ежемесячно
-11.73%
Ежегодный
-49.29%
Q1 прогноз
19.27




Кредиторская задолженность Изменить Дата
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Immunic USD 7.92M 25K 2025-09
Insmed USD 79.91M 316K 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Kyowa Hakko Kirin JPY 125.04B 1.32B 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
Moderna USD 317M 50M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Xoma USD 2.65M 1.52M 2025-09